NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 6.33% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.74% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 4.38% |
| 326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 4.38% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 4.31% |
| SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.30% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 4.19% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.16% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.97% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 3.90% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 3.87% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 3.82% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.78% |
| IART | Integra LifeSciences Holdings | Healthcare | Medical Devices | 3.70% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
| BHVN | Biohaven Pharmaceutical Holding Co Ltd | Healthcare | Biotechnology | 3.56% |
| EWTX | Edgewise Therapeutics Inc | Healthcare | Biotechnology | 3.41% |